Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pomalidomide

EU orphan designation number: EU/3/10/757   
Active ingredient: Pomalidomide
Indication: Treatment of primary myelofibrosis
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2010 Centralised Orphan - Designation EMA/OD/161/09 (2010)5341 of 27/07/2010
30/05/2011 Other procedure EMEA/OD/161/09